Stock Analysis

Should You Think About Buying Cosmax Nbt, Inc. (KOSDAQ:222040) Now?

KOSDAQ:A222040
Source: Shutterstock

Cosmax Nbt, Inc. (KOSDAQ:222040), is not the largest company out there, but it saw a decent share price growth in the teens level on the KOSDAQ over the last few months. Less-covered, small caps sees more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Let’s examine Cosmax Nbt’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

View our latest analysis for Cosmax Nbt

What is Cosmax Nbt worth?

Great news for investors – Cosmax Nbt is still trading at a fairly cheap price. My valuation model shows that the intrinsic value for the stock is ₩12117.08, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Cosmax Nbt’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

What kind of growth will Cosmax Nbt generate?

earnings-and-revenue-growth
KOSDAQ:A222040 Earnings and Revenue Growth January 5th 2021

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With revenues expected to grow by 47% over the next couple of years, the future seems bright for Cosmax Nbt. If the level of expenses is able to be maintained, it looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? Since A222040 is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on A222040 for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy A222040. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

If you want to dive deeper into Cosmax Nbt, you'd also look into what risks it is currently facing. At Simply Wall St, we found 1 warning sign for Cosmax Nbt and we think they deserve your attention.

If you are no longer interested in Cosmax Nbt, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

If you decide to trade Cosmax Nbt, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About KOSDAQ:A222040

Cosmax Nbt

Operates as a health functional food company in South Korea and internationally.

Mediocre balance sheet and slightly overvalued.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|50.46000000000001% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|18.292% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|20.485999999999997% undervalued
Maxell
Maxell
Community Contributor